MS
RXDX

Maven Securities’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Maven Securities’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Hold
0
– – – 637
2023
Q2 		– Hold
0
– – – 561
2021
Q2 		– Sell
-8,333
Closed -$152K – 1101
2021
Q1 		$152K Buy
+8,333
New +$152K 0.01% 583